electrophoresis
Rna Diagnostics Completes Phase I Trial for Breast Cancer Treatment Test, Aims for 2025 Launch
Premium
The firm's RNA Disruption Assay measures ribosomal RNA fragmentation to determine whether a cancer treatment is working and aid decisions whether to change course.
4D Lifetec Raises $1.9M in Series B Financing to Support Lung Cancer Detection Test Launch
The company is hoping to accelerate its activities in Europe and is preparing to bring the cell-based test to the US by the end of next year.
Mylab, Hemex Health Partner to Develop POC Dx Tests
The companies will use fluorescence immunoassays and electrophoresis-based diagnostic solutions and will jointly introduce tests in the US, Europe, and Asia.
Sebia to Develop Dx Test for Sanofi Multiple Myeloma Treatment
The IVD test will adjust for isatuximab-induced interference in immunofixation electrophoresis tests, which can mislead clinicians in interpreting patient response.
Rna Diagnostics is hoping to make its RDA assay available as a laboratory-developed test for research use next year before offering it to clinicians in 2020.